CS-Keys
closedBiotechnology company discovers and develops cancer-associated biomarkers using proteomics.
Launch date
Employees
Market cap
-
Enterprise valuation
$25—38m (Dealroom.co estimates Jan 2008.)
Indianapolis Indiana (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$290k | Seed | ||
$6.3m | Series A | ||
Total Funding | $6.6m |
Recent News about CS-Keys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.